360 related articles for article (PubMed ID: 33173205)
41. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Sargos P; Chabaud S; Latorzeff I; Magné N; Benyoucef A; Supiot S; Pasquier D; Abdiche MS; Gilliot O; Graff-Cailleaud P; Silva M; Bergerot P; Baumann P; Belkacemi Y; Azria D; Brihoum M; Soulié M; Richaud P
Lancet Oncol; 2020 Oct; 21(10):1341-1352. PubMed ID: 33002438
[TBL] [Abstract][Full Text] [Related]
43. Surgical management of lymph-node-positive prostate cancer: improves symptomatic control.
Wiegand LR; Hernandez M; Pisters LL; Spiess PE
BJU Int; 2011 Apr; 107(8):1238-42. PubMed ID: 20880197
[TBL] [Abstract][Full Text] [Related]
44. Laparoscopic Radical Prostatectomy Plus Extended Lymph Node Dissection in Combination With Immediate Androgen Deprivation Therapy for Cases of pT3-4N0-1M0 Prostate Cancer: A Multimodal Study of 8 Years' Follow-up.
Yang Y; Luo Y; Hou GL; Huang QX; Pang J; Gao X
Clin Genitourin Cancer; 2016 Aug; 14(4):e321-7. PubMed ID: 26691668
[TBL] [Abstract][Full Text] [Related]
45. Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis.
Wettstein MS; David LA; Pazhepurackel C; Qureshi AA; Zisman A; Nesbitt M; Saba K; Herrera-Caceres JO; Fankhauser CD; Ahmad A; Hamilton RJ; Eberli D; Zlotta AR; Sulser T; Fleshner NE; Poyet C; Finelli A; Hermanns T; Kulkarni GS
Prostate; 2021 Apr; 81(5):286-294. PubMed ID: 33599318
[TBL] [Abstract][Full Text] [Related]
46. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
47. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
48. [Place of surgery in high-risk tumours of the prostate].
Soulié M; Rozet F; Hennequin C; Salomon L;
Cancer Radiother; 2010 Oct; 14(6-7):493-9. PubMed ID: 20727805
[TBL] [Abstract][Full Text] [Related]
49. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
50. [Extended salvage pelvic and retroperitoneal lymph node dissection due to prostate cancer relapse].
Osmonov DK; Aksenov AV; Jünemann KP
Aktuelle Urol; 2013 Jan; 44(1):50-2. PubMed ID: 23325670
[TBL] [Abstract][Full Text] [Related]
51. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
[TBL] [Abstract][Full Text] [Related]
52. Robotic-assisted pelvic lymph node dissection for prostate cancer: frequency of nodal metastases and oncological outcomes.
Ledezma RA; Negron E; Razmaria AA; Dangle P; Eggener SE; Shalhav AL; Zagaja GP
World J Urol; 2015 Nov; 33(11):1689-94. PubMed ID: 25701128
[TBL] [Abstract][Full Text] [Related]
53. A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer.
Ventimiglia E; Seisen T; Abdollah F; Briganti A; Fonteyne V; James N; Roach M; Thalmann GN; Touijer K; Chen RC; Cheng L
Eur Urol Oncol; 2019 May; 2(3):294-301. PubMed ID: 31200844
[TBL] [Abstract][Full Text] [Related]
54. Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.
Fujimoto N; Shiota M; Tomisaki I; Minato A; Yahara K
Urol Int; 2019; 103(2):125-136. PubMed ID: 31039571
[TBL] [Abstract][Full Text] [Related]
55. High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy.
Ost P; Cozzarini C; De Meerleer G; Fiorino C; De Potter B; Briganti A; Nagler EV; Montorsi F; Fonteyne V; Di Muzio N
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):960-5. PubMed ID: 22172901
[TBL] [Abstract][Full Text] [Related]
56. Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy.
Zareba P; Eastham J; Scardino PT; Touijer K
J Urol; 2017 Nov; 198(5):1077-1084. PubMed ID: 28625507
[TBL] [Abstract][Full Text] [Related]
57. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.
Bhindi B; Rangel LJ; Mason RJ; Gettman MT; Frank I; Kwon ED; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
J Urol; 2017 Jul; 198(1):86-91. PubMed ID: 28130104
[TBL] [Abstract][Full Text] [Related]
58. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies.
Touijer KA; Karnes RJ; Passoni N; Sjoberg DD; Assel M; Fossati N; Gandaglia G; Eastham JA; Scardino PT; Vickers A; Cozzarini C; Montorsi F; Briganti A
Eur Urol; 2018 Jun; 73(6):890-896. PubMed ID: 29042125
[TBL] [Abstract][Full Text] [Related]
59. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice.
Panje C; Zilli T; Dal Pra A; Arnold W; Brouwer K; Garcia Schüler HI; Gomez S; Herrera F; Khanfir K; Papachristofilou A; Pesce G; Reuter C; Vees H; Zwahlen D; Putora PM
Radiat Oncol; 2019 Oct; 14(1):177. PubMed ID: 31619296
[TBL] [Abstract][Full Text] [Related]
60. Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results.
Abbas F; Kaplan M; Soloway MS
Br J Urol; 1996 Mar; 77(3):423-8. PubMed ID: 8814850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]